Remote Monitored Systems PLC (LON:RMS) has provided another update on the progress of the antiviral face-mask being produced by its Pharm 2 Farm (P2F) subsidiary.
Following the submission of three batches of prototype masks for certification to PPE standard EN14683, the masks have undergone preliminary breathability testing.
One of the masks, a four-ply mask including an anti-viral layer, passed this breathability test, while the pair of five-ply masks with the antiviral layer failed this stage of the breathability test and require modification.
RMS said it will provide further updates as appropriate.
Pharm2Farm’s Antiviral Face Mask USPs
1. Better protects
2. Longer life
3. Better price-performancehttps://t.co/CmBTXNZk4z
— Pharm2Farm (@Pharm2Farm_org) November 24, 2020
